Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Ombitasvir 13C2D6

Stable Isotopes
CAT No.
:
CS-O-13401

CAS No.

:

1258226-87-7 (Unlabeled)

Molecular Weight

:

902.13

Molecular Formula

:

C48[1C]2H61D6N7O8

Purity

:

>98%

HS Code:

:

28459090

 


Useful information

"Ombitasvir is an antiviral drug for the treatment of hepatitis C virus (HCV) infection. In the United States, it is approved by the Food and Drug Administration for use in combination with paritaprevir, ritonavir and dasabuvir in the product Viekira Pak for the treatment of HCV genotype 1, and with paritaprevir and ritonavir in the product Technivie for the treatment of HCV genotype 4.

Ombitasvir is an NS5A inhibitor that acts by inhibiting the HCV protein NS5A.",""



Product Application Notes

Labeled Ombitasvir , intended for use as an internal standard for the quantification of Ombitasvir by GC- or LC-mass spectrometry.



Synonyms

(13C,D3)methyl N-[(2S)-1-[(2S)-2-({4-[(2S,5S)-1-(4-tert-butylphenyl)-5-{4-[(2S)-1-[(2S)-2-{[(13C,D3)methoxycarbonyl]amino}-3-methylbutanoyl]pyrrolidine-2-amido]phenyl}pyrrolidin-2-yl]phenyl}carbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate



References

AbbVie Inc., North Chicago, IL 60064. Retrieved 30 July 2015; Food and Drug Administration. December 19, 2014.



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Ombitasvir 13C2D6 Cas # 1258226-87-7 (Unlabeled) and its Stable Isotopes.

Ombitasvir 13C2D6 Ombitasvir 13C2D6 Worldwide Suppliers of Ombitasvir 13C2D6 Stable Isotopes Clearsynth 1258226-87-7 (Unlabeled)

Product rating: 9 Ombitasvir 13C2D6 based on 20 ratings

  1. Stable Isotopes

  2. Ombitasvir 13C2D6



Keywords

Keywords: Stable Isotopes (13C,D3)methyl N-[(2S)-1-[(2S)-2-({4-[(2S,5S)-1-(4-tert-butylphenyl)-5-{4-[(2S)-1-[(2S)-2-{[(13C,D3)methoxycarbonyl]amino}-3-methylbutanoyl]pyrrolidine-2-amido]phenyl}pyrrolidin-2-yl]phenyl}carbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate CS-O-13401 Ombitasvir 13C2D6 Ombitasvir 1258226-87-7 (Unlabeled) 902.13 C48[1C]2H61D6N7O8
Internal standard, Internal standard Ombitasvir, HPLC-MS method validation, HPLC-MS method validation Ombitasvir, LC-MS-MS method validation, LC-MS-MS method validation Ombitasvir, Deuterated internal standard, Deuterated internal standard Ombitasvir, Deuterated Ombitasvir, Deuterium labeled Ombitasvir, Quantitative bioanalytical methods, Quantitative bioanalytical methods Ombitasvir, Blood samples Ombitasvir, Blood concentrations, Heavy drugs, Analysis, Analysis Ombitasvir, Clinical diagnostic, Clinical diagnostic Ombitasvir, Dosing Ombitasvir, Analytical method development, Internal standard method.



Related result for 'Ombitasvir 13C2D6'

- Ombitasvir : API Standards

- Ombitasvir : Stable Isotopes

- Ombitasvir : Impurities



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945